News & Perspective

Sep 22, 2009

Sep 22, 2009

Business conference airs challenges of H1N1 vaccine campaign

(CIDRAP News) – With the second wave of the H1N1 influenza virus now hitting, much of the response toe the pandemic is focused on the development and distribution of an effective vaccine, a project that poses many challenges and uncertainties.

Feb 16, 2005

Feb 16, 2005

Study: Flu shots in elderly don't cut mortality rate

(CIDRAP News) – Researchers who tracked national data on influenza vaccination rates and mortality in elderly people from 1968 through 2001 say they could find no evidence that flu shots reduced death rates.

Feb 11, 2005

Feb 11, 2005

FLU SERIES CDC: Flu vaccine reached those in need

(CIDRAP News) – Influenza vaccine doses intended for those at highest risk for serious complications from the flu made it into the arms of the right people, the Centers for Disease Control and Prevention (CDC) in Atlanta said yesterday.

Jan 07, 2005

Jan 07, 2005

FLU SERIES Toddler vaccinations a bright spot in flu season

(CIDRAP News) – The new recommendation to vaccinate children between 6 and 23 months old could have been lost in the hubbub of the influenza vaccine shortage this season. Yet authorities are terming this year's vaccination rates a success story.

Dec 09, 2004

Dec 09, 2004

Flu vaccine shortage spurs freelance shots, profiteering

(CIDRAP News) – Freelance vaccinations and offers of bootleg vaccine are two unusual side effects of the US influenza vaccine shortage.

Oct 28, 2004

Oct 28, 2004

FLU SERIES Scrambling for vaccine: A sampling of responses

(CIDRAP News) – The United States was on track to provide 100 million doses of influenza vaccine this year when half of its supply was withdrawn in early October because of contamination concerns over vaccine from Chiron Corp. Suddenly about 48 million doses shy of the expected supply, US officials scrambled to define priorities.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»